Sonographic and Hysteroscopic Surveillance in Women with Breast Cancer Treated with Tamoxifen: A Retrospective Study

[1]  O. Tsonis,et al.  Comparative retrospective study on transvaginal sonography versus office hysteroscopy in the diagnosis of endometrial pathology among different subgroups , 2020, The journal of obstetrics and gynaecology research.

[2]  G. Emons,et al.  Tamoxifen and Endometrial Cancer: A Janus-Headed Drug , 2020, Cancers.

[3]  Maria Lee,et al.  Risk Factors Associated with Endometrial Pathology in Premenopausal Breast Cancer Patients Treated with Tamoxifen , 2020, Yonsei medical journal.

[4]  K. Gelmon,et al.  ESO-ESMO 4rd International Consensus Guidelines for Breast Cancer in Young Women (BCY4). , 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

[5]  Marwa Romeih,et al.  Role of transvaginal ultrasound in detection of endometrial changes in breast cancer patients under hormonal therapy , 2019, Egyptian Journal of Radiology and Nuclear Medicine.

[6]  S. Coughlin.  Epidemiology of Breast Cancer in Women. , 2013, Advances in experimental medicine and biology.

[7]  M. Um,et al.  Comparative Study on Hysteroscopic and Histologic Examinations of the Endometrium in Postmenopausal Women Taking Tamoxifen , 2018, Journal of menopausal medicine.

[8]  M. G. Pereira,et al.  Factors Associated with Malignancy in Hysteroscopically Resected Endometrial Polyps: A Systematic Review and Meta-Analysis. , 2018, Journal of minimally invasive gynecology.

[9]  H. Bolton,et al.  Post-menopausal bleeding – Is transvaginal ultrasound a useful first-line investigation in tamoxifen users? , 2018, Post reproductive health.

[10]  K. Isaacson,et al.  Office Operative Hysteroscopy: An Update. , 2017, Journal of minimally invasive gynecology.

[11]  N. Park,et al.  Endometrial polyp surveillance in premenopausal breast cancer patients using tamoxifen , 2017, Obstetrics & gynecology science.

[12]  A. Di Spiezio Sardo,et al.  Gynaecological endoscopic surgical education and assessment. A diploma programme in gynaecological endoscopic surgery , 2016, Gynecological Surgery.

[13]  V. Phupong,et al.  Diagnostic accuracy of 3D-transvaginal ultrasound in detecting uterine cavity abnormalities in infertile patients as compared with hysteroscopy. , 2016, European journal of obstetrics, gynecology, and reproductive biology.

[14]  J. Forbes,et al.  Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials , 2015, The Lancet.

[15]  Balwinder Kaur,et al.  Endometrial evaluation by ultrasonography, hysteroscopy and histopathology in cases of breast carcinoma on Tamoxifen therapy , 2015, Journal of mid-life health.

[16]  A. Olejek,et al.  The value of hysteroscopic-based decision-making in uterine abnormalities during tamoxifen intake in breast cancer patients – preliminary report , 2014, Wideochirurgia i inne techniki maloinwazyjne = Videosurgery and other miniinvasive techniques.

[17]  Committee Opinion No. 601: Tamoxifen and uterine cancer. , 2014, Obstetrics and gynecology.

[18]  P. Sismondi,et al.  Suspecting malignancy in endometrial polyps: value of hysteroscopy. , 2013, Tumori.

[19]  A. Alibrandi,et al.  Endometrial pathology in breast cancer patients: Effect of different treatments on ultrasonographic, hysteroscopic and histological findings , 2013, Oncology letters.

[20]  A. Lev-Toaff,et al.  Imaging of the female pelvis through the life cycle. , 2012, Radiographics : a review publication of the Radiological Society of North America, Inc.

[21]  M. McHugh.  Interrater reliability: the kappa statistic , 2012, Biochemia medica.

[22]  Early Breast Cancer Trialists' Collaborative Group.  Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials , 2011, The Lancet.

[23]  Wan-li Gao,et al.  Comparative study of transvaginal ultrasonographic and diagnostic hysteroscopic findings in postmenopausal breast cancer patients treated with tamoxifen. , 2011, Chinese medical journal.

[24]  C. Zettler,et al.  Tamoxifen use and endometrial lesions: hysteroscopic, histological, and immunohistochemical findings in postmenopausal women with breast cancer , 2009, Menopause.

[25]  S. Ascher,et al.  The effect of tamoxifen on the genital tract , 2008, Cancer imaging : the official publication of the International Cancer Imaging Society.

[26]  A. Chattopadhyay,et al.  Tamoxifen Therapy for Breast Cancer and Endometrial Pathology. , 2005, Medical journal, Armed Forces India.

[27]  Y. Alamanos,et al.  Selecting distending medium for out-patient hysteroscopy. Does it really matter? , 2004, Human reproduction.

[28]  O. Ceci,et al.  Operative office hysteroscopy without anesthesia: analysis of 4863 cases performed with mechanical instruments. , 2004, The Journal of the American Association of Gynecologic Laparoscopists.

[29]  S. Leodolter,et al.  Association between endometrial cancer and tamoxifen treatment of breast cancer , 1999, Breast Cancer Research and Treatment.

[30]  D. Crivellari,et al.  Comparison of ultrasonography, hysteroscopy, and biopsy in the diagnosis of endometrial lesions in postmenopausal tamoxifen‐treated patients , 2002, Acta obstetricia et gynecologica Scandinavica.

[31]  O. Ceci,et al.  Comparison of hysteroscopic and hysterectomy findings for assessing the diagnostic accuracy of office hysteroscopy. , 2002, Fertility and sterility.

[32]  F. Grossi,et al.  Saline infusion sonography and office hysteroscopy to assess endometrial morbidity associated with tamoxifen intake. , 2002, Gynecologic oncology.

[33]  Y. Alamanos,et al.  Vaginoscopic hysteroscopy and transvaginal sonography in the evaluation of patients with abnormal uterine bleeding. , 2001, The Journal of the American Association of Gynecologic Laparoscopists.

[34]  O. Ceci,et al.  Hysteroscopic evaluation of the endometrium in postmenopausal women taking tamoxifen. , 2000, The Journal of the American Association of Gynecologic Laparoscopists.

[35]  P. Neven,et al.  Guidelines for Monitoring Patients Taking Tamoxifen Treatment , 2000, Drug safety.

[36]  B. Muir,et al.  Investigation of endometrial abnormalities in asymptomatic women treated with tamoxifen and an evaluation of the role of endometrial screening. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  T. Bourne,et al.  A randomized trial on the use of ultrasonography or office hysteroscopy for endometrial assessment in postmenopausal patients with breast cancer who were treated with tamoxifen. , 1998, American journal of obstetrics and gynecology.

[38]  S. Goldstein,et al.  The use of transvaginal ultrasound and saline infusion sonohysterography for the evaluation of asymptomatic postmenopausal breast cancer patients on tamoxifen , 1998, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

[39]  S. Ozşener,et al.  Endometrial pathology of 104 postmenopausal breast cancer patients treated with tamoxifen. , 1998, European journal of gynaecological oncology.

[40]  M. Paschopoulos,et al.  Vaginoscopic approach to outpatient hysteroscopy. , 1997, The Journal of the American Association of Gynecologic Laparoscopists.

[41]  I. Cohen,et al.  Transvaginal Sonography of the Uterine Cavity with Hysteroscopic Correlation in the Investigation of Infertility , 1993, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[42]  Walter G. Gunn,et al.  American Cancer Society Textbook of Clinical Oncology , 1992 .

[43]  P. Neven,et al.  Hysteroscopic follow-up during tamoxifen treatment. , 1990, European journal of obstetrics, gynecology, and reproductive biology.